BioSpace News Archive

Hansoh Pharmaceutical Group Company Limited announced that the National Medical Products Administration has granted marketing authorization for AMEILE once daily tablets for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer, who have progressed on or after other EGFR tyrosine kinase inhibitor therapy.

The Hazelden Betty Ford Foundation is bringing addiction treatment to people wherever they may be—including to those currently at home due to the coronavirus—with its RecoveryGo™ telehealth solutions, which expanded this month with the launch of insurance-covered group therapy—connecting patients and their counselor in real-time via personal computers and mobile devices.

VitalHub Corp. announced that it will be deploying its patient flow solution, utilizing its Oculys Performance technology, for five hospitals in Windsor and Essex County to assist them in their efforts to plan for and manage patient flow in the face of a possible COVID-19 pandemic.

-Todos Medical Ltd.today announced it has entered into an exclusive distribution agreement for the United States and Israel (the “Distribution Agreement”) with Gibraltar Brothers & Associates, LLC, a U.S.-based subsidiary of Shanghai Liangrun Biomedicine Technology Co.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country, covering its T2Dx ® Instrument, as well as the T2Bacteria ® and T2Candida ® Panels, that detect sepsis-causing bacterial and fungal pathogens directly from whole blood.

As the first company to offer direct-to-patient, at-home mental health pharmacogenetic testing, Genomind is helping patients and physicians gain actionable mental health insights without having to leave their homes

Successfully completes single ascending dose phase of first clinical study in healthy subjects for a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation Invasive Pulmonary Aspergillosis is a severe fungal pulmonary disease with a mortality rate that can reach 90 percent¹ in some patient populations AUSTIN, Texas--( BUSINESS WIRE )-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on de

COVID-19 continues to spread across the world, especially in Europe. According to John Hopkins University’s latest real-time statistics, as of 10:00 a.m.

today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on the status of its Phase 3 PHALCON-EE and PHALCON-HP clinical trials and other business matters.

Agritek Holdings, Inc. (AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor and white label provide for popular hemp brands, today announced that the Company has completed the acquisition and definitive agreement to acquire all of the issued and outstanding shares of Full Spectrum Biosciences Inc.,